Show simple item record

dc.contributor.authorMalaina Celada, Iker ORCID
dc.contributor.authorMartínez Fernández, Luis ORCID
dc.contributor.authorSalcines Cuevas, David
dc.contributor.authorTerán Navarro, Héctor
dc.contributor.authorOcejo Vinyals, Javier Gonzalo
dc.contributor.authorGonzález López, Elena
dc.contributor.authorSoriano, Vicente
dc.contributor.authorUbeda, María
dc.contributor.authorPérez Pinilla, Martín Blas ORCID
dc.contributor.authorMartínez de la Fuente Martínez, Ildefonso Abel
dc.contributor.authorÁlvarez Domínguez, Carmen
dc.date.accessioned2024-05-06T16:35:17Z
dc.date.available2024-05-06T16:35:17Z
dc.date.issued2023
dc.identifier.citationScientific Reports 13 : (2023) // Article ID 21746es_ES
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/10810/67537
dc.description.abstractThis paper presents a new procedure for vaccine design against highly variable viruses such as Hepatitis C. The procedure uses an optimization algorithm to design vaccines that maximize the coverage of epitopes across different virus variants. Weighted epitopes based on the success ratio of immunological assays are used to prioritize the selection of epitopes for vaccine design. The procedure was successfully applied to design DC vaccines loaded with two HCV peptides, STG and DYP, which were shown to be safe, immunogenic, and able to induce significant levels of anti-viral cytokines, peptide-specific cellular immune responses and IgG antibodies. The procedure could potentially be applied to other highly variable viruses that currently lack effective vaccines.es_ES
dc.description.sponsorshipOur research also received funding from the Department of Education of the Basque Government via the Consolidated Research Group MATH MODE (IT1456-22). LM and IM were supported by the UPV/EHU and Basque Center of Applied Mathematics, grant US21/27. Furthermore, CA. was supported by the European COST action ENOVA-CA-16231 and UNIR grant B0036-2223. We also must thank Alfonso Berroya Elosua for the graphic design.es_ES
dc.language.isoenges_ES
dc.publisherNaturees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleTesting a vaccine candidate against Hepatitis C virus designed by combinatorial optimizationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.nature.com/articles/s41598-023-48458-xes_ES
dc.identifier.doi10.1038/s41598-023-48458-x
dc.departamentoesMatemáticases_ES
dc.departamentoeuMatematikaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's license is described as © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.